[Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
D000241:Adenosine / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D004176:Dipyridamole / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004734:Energy Metabolism / Q000187:drug effects; D005029:Ethylenediamines / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D010710:Phosphates / Q000378:metabolism; D013053:Spectrophotometry; D014665:Vasodilator Agents / Q000494:pharmacology*
D001381:Azepines; D001565:Benzoates; D005029:Ethylenediamines; D010710:Phosphates; D014665:Vasodilator Agents; D004176:Dipyridamole; D000241:Adenosine; D010100:Oxygen